Cargando…

CD8(+) tumor‐infiltrating lymphocytes contribute to spontaneous “healing” in HER2‐positive ductal carcinoma in situ

We evaluated the associations between tumor‐infiltrating lymphocytes (TIL) including CD8‐positive [+] lymphocytes in ductal carcinoma in situ (DCIS) and histopathologic factors, particularly spontaneous “healing” and immunohistochemical (IHC)‐based subtypes, to clarify the effects of host immune res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morita, Michi, Yamaguchi, Rin, Tanaka, Maki, Tse, Gary M., Yamaguchi, Miki, Kanomata, Naoki, Naito, Yoshiki, Akiba, Jun, Hattori, Satoshi, Minami, Shigeki, Eguchi, Susumu, Yano, Hirohisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944888/ https://www.ncbi.nlm.nih.gov/pubmed/27061242 http://dx.doi.org/10.1002/cam4.715

Ejemplares similares

Prognostic implications of HER2 heterogeneity in gastric cancer
por: Motoshima, Shigenobu, et al.
Publicado: (2018)

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
por: TAKENAKA, MIKI, et al.
Publicado: (2013)

Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer
por: Muroya, Daisuke, et al.
Publicado: (2016)

CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature
por: Kanomata, Naoki, et al.
Publicado: (2019)

Histopathology of non-mass-like breast lesions on ultrasound
por: Yamaguchi, Rin, et al.
Publicado: (2023)

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
por: Yutani, Shigeru, et al.
Publicado: (2017)

ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells
por: Fukushima, Hiroto, et al.
Publicado: (2016)

CD44v3(+)/CD24(−) cells possess cancer stem cell-like properties in human oral squamous cell carcinoma
por: TODOROKI, KEITA, et al.
Publicado: (2015)

Expression and role of regulator of G‐protein signaling 5 in squamous cell carcinoma of the tongue
por: Abe, Yushi, et al.
Publicado: (2019)

Acute appendicitis associated with the presence of schistosome eggs in a sailor: a case report
por: Imamura, Hajime, et al.
Publicado: (2019)

Long-term Survival after Resection of HER2+ Infiltrating Ductal Carcinoma Metastasis to the Brainstem
por: Awad, Al-Wala, et al.
Publicado: (2016)

Prognosis of asymptomatic versus symptomatic metastatic breast cancer: a multicenter retrospective study
por: Kuba, Sayaka, et al.
Publicado: (2022)

A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy
por: Naito, Yoshiki, et al.
Publicado: (2021)

Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement
por: AKIBA, JUN, et al.
Publicado: (2014)

Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ
por: Estévez, Laura G, et al.
Publicado: (2014)

Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ
por: Xu, Fei-Fei, et al.
Publicado: (2021)

Lymphedema After Axillary Lymph Node Dissection in Breast Cancer: Prevalence and Risk Factors—A Single-Center Retrospective Study
por: Hara, Yuki, et al.
Publicado: (2022)

Fibroadenoma progress to ductal carcinoma in situ, infiltrating ductal carcinoma and lymph node metastasis? Report an unusual case
por: Wu, Yu-Ting, et al.
Publicado: (2017)

Squamous cell carcinoma with apocrine features of the breast: A case report
por: NAITO, YOSHIKI, et al.
Publicado: (2014)

Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts
por: Ban, Kanako, et al.
Publicado: (2019)

An atypical presentation of infiltrating ductal carcinoma
por: Jha, Kunal Kishor, et al.
Publicado: (2016)

Infiltrating ductal carcinoma breast with central necrosis closely mimicking ductal carcinoma in situ (comedo type): a case series
por: Pervez, Shahid, et al.
Publicado: (2007)

Surgical excision of a lactating adenoma with rapid enlargement: A case report
por: Hara, Yuki, et al.
Publicado: (2021)

Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells
por: Agahozo, Marie Colombe, et al.
Publicado: (2021)

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
por: Badve, Sunil S., et al.
Publicado: (2022)

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
por: Kuroda, Hajime, et al.
Publicado: (2021)

Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients
por: Iwasa, Satoru, et al.
Publicado: (2016)

Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling
por: Pradeep, Chaluvally-Raghavan, et al.
Publicado: (2011)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
por: Kuroda, Hajime, et al.
Publicado: (2021)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
por: Lee, A. H., et al.
Publicado: (1996)

Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma
por: Hori, Mika, et al.
Publicado: (2014)

HER2 overexpression in ductal carcinoma in situ is associated with ipsilateral breast cancer recurrence after conservative surgery
por: Gong, Di-He, et al.
Publicado: (2020)

Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2
por: Solek, Julia, et al.
Publicado: (2022)

Pan‐HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK ‐rearranged lung cancer
por: Taniguchi, Hirokazu, et al.
Publicado: (2022)

Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06)
por: Masuyama, Misato, et al.
Publicado: (2023)

Impact of endoscopic submucosal dissection and epithelial cell sheet engraftment on systemic cytokine dynamics in patients with oesophageal cancer
por: Yoshida, Akira, et al.
Publicado: (2021)

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity
por: Wilson, G R, et al.
Publicado: (2006)

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
por: Borgquist, Signe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_anh4a39vdirta61tpeen5199ft